Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05256095 · ClinicalTrials.gov registry record · NA

Thinking in Speech for Children With Autism

A NA study of Autism Spectrum Disorder and Speech, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT05256095 is a NA study of Autism Spectrum Disorder and Speech that has completed, run by University of Pittsburgh. The registered enrollment target is 22 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05256095, a NA study of Autism Spectrum Disorder and Speech, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

This study examines a cognitive therapy for autistic children, Thinking in Speech. Thinking in Speech helps children with autism independently cope with everyday events that cause stress, by developing their ability to use "inner speech".

Interventions

  • BEHAVIORAL Thinking in Speech

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2021-05-12
Est. Completion 2022-08-10
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT05256095

The ClinicalTrials.gov registry entry for NCT05256095 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (84% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Thinking in Speech is the first listed.

NCT05256095 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05256095 about?

NCT05256095 is a clinical study titled "Thinking in Speech for Children With Autism". This study examines a cognitive therapy for autistic children, Thinking in Speech. Thinking in Speech helps children with autism independently cope with everyday events that cause stress, by developing their ability to use "inner speech".

What is the current status of trial NCT05256095?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2021-05-12. Estimated completion is 2022-08-10.

What conditions does trial NCT05256095 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Speech.

What interventions are being tested in trial NCT05256095?

The interventions under investigation include: Thinking in Speech (BEHAVIORAL).

Who is sponsoring clinical trial NCT05256095?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05256095 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.